1. Home
  2. RVLV vs GALT Comparison

RVLV vs GALT Comparison

Compare RVLV & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

HOLD

Current Price

$23.66

Market Cap

1.8B

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$2.54

Market Cap

199.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVLV
GALT
Founded
2003
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
199.2M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
RVLV
GALT
Price
$23.66
$2.54
Analyst Decision
Buy
Strong Buy
Analyst Count
12
2
Target Price
$29.73
$8.50
AVG Volume (30 Days)
707.7K
332.0K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
24.64
36.84
EPS
0.86
N/A
Revenue
$1,225,682,000.00
N/A
Revenue This Year
$10.96
N/A
Revenue Next Year
$8.01
N/A
P/E Ratio
$25.87
N/A
Revenue Growth
8.48
N/A
52 Week Low
$16.80
$1.22
52 Week High
$31.68
$7.13

Technical Indicators

Market Signals
Indicator
RVLV
GALT
Relative Strength Index (RSI) 52.67 38.30
Support Level $20.18 $2.07
Resistance Level $24.30 $3.32
Average True Range (ATR) 0.90 0.20
MACD 0.21 -0.03
Stochastic Oscillator 100.00 3.69

Price Performance

Historical Comparison
RVLV
GALT

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: